NUBEQA HELPS YOU LIVE FOR WHAT YOU LOVE
Learn more at NUBEQA.com.
NUBEQA clinical study was designed to measure metastasis-free survival (MFS) and also overall survival (OS). NUBEQA extended OS by lowering the risk of death by 31% compared with hormone therapy alone. IMPORTANT SAFETY INFORMATION (continued) The most common side effects of NUBEQA in people with nmCRPC include (continued): NUBEQA may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility. These are not all the possible side effects of NUBEQA. Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Please see additional Important Safety Information throughout and the full Prescribing Information.
© 2023 Bayer. All rights reserved. BAYER, the Bayer Cross and NUBEQA are registered trademarks of Bayer, and Access Services by Bayer is a trademark of Bayer. PP-NUB-US-2560-1 11/23
Made with FlippingBook flipbook maker